PT1783118E - Preparação de risperidona - Google Patents

Preparação de risperidona Download PDF

Info

Publication number
PT1783118E
PT1783118E PT07001138T PT07001138T PT1783118E PT 1783118 E PT1783118 E PT 1783118E PT 07001138 T PT07001138 T PT 07001138T PT 07001138 T PT07001138 T PT 07001138T PT 1783118 E PT1783118 E PT 1783118E
Authority
PT
Portugal
Prior art keywords
risperidone
preparation
disclosed
methods
present
Prior art date
Application number
PT07001138T
Other languages
English (en)
Portuguese (pt)
Inventor
Judith Aronhime
Dov Diller
Barnaba Krochmal
Ben-Zion Dolitzky
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26919535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1783118(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of PT1783118E publication Critical patent/PT1783118E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT07001138T 2000-08-14 2001-08-14 Preparação de risperidona PT1783118E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22536100P 2000-08-14 2000-08-14
US24326300P 2000-10-25 2000-10-25

Publications (1)

Publication Number Publication Date
PT1783118E true PT1783118E (pt) 2008-08-19

Family

ID=26919535

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07001138T PT1783118E (pt) 2000-08-14 2001-08-14 Preparação de risperidona

Country Status (20)

Country Link
US (2) US6750341B2 (OSRAM)
EP (2) EP1317434A4 (OSRAM)
JP (3) JP3751942B2 (OSRAM)
KR (2) KR100818875B1 (OSRAM)
AT (1) ATE401313T1 (OSRAM)
AU (1) AU2001284880A1 (OSRAM)
CA (1) CA2419314C (OSRAM)
CZ (1) CZ2003668A3 (OSRAM)
DE (1) DE60134899D1 (OSRAM)
ES (1) ES2310410T3 (OSRAM)
HR (1) HRP20030154B1 (OSRAM)
HU (1) HUP0302874A2 (OSRAM)
IL (2) IL154417A0 (OSRAM)
IS (1) IS6713A (OSRAM)
MX (1) MXPA03001337A (OSRAM)
NZ (1) NZ524554A (OSRAM)
PL (1) PL365608A1 (OSRAM)
PT (1) PT1783118E (OSRAM)
SK (1) SK2982003A3 (OSRAM)
WO (1) WO2002014286A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
BR0306204A (pt) * 2002-08-30 2004-09-08 Torrent Pharmaceuticals Ltd Processo melhorado para a preparação de risperidona
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
AU2003288017A1 (en) 2002-11-13 2004-06-03 Synthon B.V. Process for making risperidone and intermediates therefor
US20040180935A1 (en) * 2003-02-28 2004-09-16 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. Crystalline form Z of rabeprazole sodium and process for preparation thereof
AU2003245028A1 (en) * 2003-04-16 2004-11-04 Hetero Drugs Limited A novel crystalline form of risperidone
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
WO2005070332A1 (en) * 2004-01-12 2005-08-04 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
DE602004009344T2 (de) * 2004-04-19 2008-07-10 Symed Labs Ltd., Hyderabad Neues verfahren zur herstellung von linezolid und verwandten verbindungen
HUP0401379A3 (en) * 2004-07-08 2006-04-28 Richter Gedeon Vegyeszet Process for the preparation of risperidon
CA2579642A1 (en) * 2004-09-08 2006-03-16 Dermatrends, Inc. Transdermal delivery of hydrophobic bioactive agents
HUP0402163A2 (en) * 2004-10-25 2006-05-29 Richter Gedeon Vegyeszet Process for the preparation of risperidone
BRPI0607669A2 (pt) * 2005-04-27 2009-09-22 Umn Pharma Inc agente para profilaxia e tratamento de pancreatite
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007093870A2 (en) * 2006-02-15 2007-08-23 Orchid Chemicals & Pharmaceuticals Limited A process for the preparation of risperidone
US7820816B2 (en) * 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
MX354603B (es) 2007-05-25 2018-03-13 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
CN102292094B (zh) 2009-01-20 2013-08-14 洛杉矶生物医学研究所在哈伯-加州大学洛杉矶分校医疗中心 增强神经药方疗效的山梨酸与苯甲酸及其衍生物
CN102786521B (zh) * 2011-05-18 2016-01-13 中国医学科学院药物研究所 利培酮晶iii型物质及制备方法与在药品和保健品中应用
CN105367570B (zh) * 2015-12-08 2017-10-10 天津市亨必达化学合成物有限公司 一种利培酮晶i型物质的制备方法
ES2936094T3 (es) 2016-06-13 2023-03-14 Syneurx Int Taiwan Corp Cocristales de benzoato de sodio y usos de los mismos
CA3027300C (en) 2016-06-13 2023-08-08 Syneurx International (Taiwan) Corp. Co-crystals of lithium benzoate and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
ES2050069B1 (es) 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
ES2074966B1 (es) 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
AU723563B2 (en) * 1996-01-26 2000-08-31 Pharmacia & Upjohn Company Use of a combination of delavirdine and one or more protease inhibitors in HIV-1 infected patients
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
US6897308B1 (en) 2000-05-05 2005-05-24 Rgp Life Sciences Limited Process for the preparation of anti-psychotic 3-[2-[-4-(6-fluoro-1,2-benziosoxazol-3-yl)-1-piperidinyl] ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
US20020115672A1 (en) * 2000-08-08 2002-08-22 Barnaba Krochmal Preparation of risperidone
US20020193386A1 (en) 2002-03-28 2002-12-19 Inigo Pfeiffer Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof

Also Published As

Publication number Publication date
CA2419314C (en) 2006-07-11
HRP20030154B1 (en) 2009-03-31
WO2002014286A9 (en) 2003-03-27
HUP0302874A2 (hu) 2003-12-29
IL154417A0 (en) 2003-09-17
MXPA03001337A (es) 2005-06-30
US20020115673A1 (en) 2002-08-22
KR20080028513A (ko) 2008-03-31
JP2008056699A (ja) 2008-03-13
EP1317434A1 (en) 2003-06-11
EP1317434A4 (en) 2005-06-22
DE60134899D1 (de) 2008-08-28
AU2001284880A1 (en) 2002-02-25
SK2982003A3 (en) 2004-10-05
HRP20030154A2 (en) 2005-04-30
CZ2003668A3 (en) 2004-04-14
IS6713A (is) 2003-02-11
EP1982980A1 (en) 2008-10-22
ATE401313T1 (de) 2008-08-15
US7256195B2 (en) 2007-08-14
ES2310410T3 (es) 2009-01-01
NZ524554A (en) 2005-07-29
WO2002014286A1 (en) 2002-02-21
PL365608A1 (en) 2005-01-10
KR100818875B1 (ko) 2008-04-01
JP3751942B2 (ja) 2006-03-08
KR20030022389A (ko) 2003-03-15
US20040229905A1 (en) 2004-11-18
IL154417A (en) 2008-11-03
CA2419314A1 (en) 2002-02-21
JP2006028192A (ja) 2006-02-02
JP2004506622A (ja) 2004-03-04
US6750341B2 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
IL154417A0 (en) Preparation of risperidone
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
PL365683A1 (en) Selected fused pyrrolocarbazoles
IL145429A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1039110A1 (zh) 以新颖的合成物及组分作为蛋白酶抑制剂
HUP0401213A3 (en) Compounds effecting glucokinase, process for their preparation and their use for production of pharmaceutical compositions
HUP0302257A3 (en) 4-hydrazino-5-hydroxy-5-pyrazol derivatives, pharmaceutical compositions containing them, process for producing them and their intermediates
WO2002055501A3 (en) N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
HUP0201646A3 (en) Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them
GB0003154D0 (en) Novel compounds
MY129422A (en) Medicinal compounds
WO2001047928A3 (de) Imidazo 1,3,5 triazinone und ihre verwendung
GB0004128D0 (en) Novel compounds
IL156280A0 (en) Crystalline forms of atorvastatin
WO2002094774A3 (en) Oxcarbazepine dosage forms
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2005063764A3 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
HUP0204563A3 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
WO2001068645A3 (en) N-cyanomethylcarboxamides and their use as protease inhibitors
WO2002076438A3 (en) Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
WO2004007441A3 (fr) Derives de 4,4' -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
YU34604A (sh) Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže
CA2535742A1 (en) Preparation of risperidone